Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with CME: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
CME
CME Group Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
CME
CME Group Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AZN
No earnings history for AZN.
CME
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±2.6%
▲
+0.16%
×0.08
Q2 FY26
±3.8%
▲
+5.00%
×1.32
Q1 FY26
±2.8%
▲
+0.46%
×0.18
Feb 4 '26
±2.9%
▲
+0.53%
×0.17
= implied
AZN realized, solid
CME realized, hatched
One scale, both sides: full bar = 5%
× = |realized| ÷ implied
Source: market data
AZN
Astrazeneca PLC
Change
186.63
· pre 186.35
· delayed
Mkt cap
$289.5B
Revenue
—
Revenue
—
CME
CME Group Inc.
Change
303.32
· pre 305.23
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$108.5B
Revenue
$1.7B
Q3 FY26
Revenue
$6.5B
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
AZN
Astrazeneca PLC
vs
CME
CME Group Inc.
186.63
pre 186.35
delayed
Price
303.32
pre 305.23
delayed
$289.5B
Mkt cap
$108.5B
—
Revenue
$1.7B
Q3 FY26
—
Revenue
$6.5B
FY25
Change
Change
AZN
186.63
vs
CME
303.32
Pre-market
Oct 30 '26
delayed